Clinical trial
Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno…
NCT00158808 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00158808 |
|---|---|
| Title | Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths |
| Official title | Assess the Immunogenicity &d Reactogenicity of a Booster Dose of a Formulation of GSK Biologicals' DTPw-HBV/Hib Vaccine at 15-18 Mths of Age in Infants Previously Primed With the Same Vaccine |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hib Disease, Hepatitis B, Pertussis, Prophylaxis of Diphtheria, Tetanus |
| Intervention type | Biological |
| Interventions | Diphteria, tetanus, whole-cell pertussis, hepatitis B & Hib |
| Enrollment | 175 |
| Start date | Jan 1, 2005 |
| Primary completion | Apr 1, 2005 |
| Completion | Apr 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | May 30, 2017 |
| Countries | Philippines |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: